MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
NeoGenomics Long Term Debt Current 2011-2026 | NEO
Annual Long Term Debt Current NeoGenomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 4.78 M | 3.38 M | 5.61 M | 6.58 M | 6.88 M | 4.97 M | 3.38 M | - | - | - | 550 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.88 M | 550 K | 4.52 M |
Long Term Debt Current of other stocks in the Diagnostics research industry
| Issuer | Long Term Debt Current | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
CareDx, Inc
CDNA
|
6.52 M | $ 20.54 | -1.25 % | $ 1.09 B |  USA |
 |
Co-Diagnostics
CODX
|
662 K | $ 1.51 | -1.63 % | $ 2.01 M | USA |
 |
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
ICON Public Limited Company
ICLR
|
24.3 M | $ 114.63 | -1.33 % | $ 9.45 B |  Irlanda |
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Lantheus Holdings
LNTH
|
3.8 M | $ 81.79 | 0.76 % | $ 5.52 B | USA |
 |
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | USA |
 |
Medpace Holdings
MEDP
|
23.2 M | $ 416.79 | 0.77 % | $ 12 B | USA |
 |
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | USA |
 |
National Research Corporation
NRC
|
451 K | $ 16.36 | -1.12 % | $ 366 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
241 M | $ 26.12 | 2.11 % | $ 20 B |  Niderland |
 |
Personalis
PSNL
|
7.7 M | $ 5.16 | 2.38 % | $ 306 M | USA |
 |
Fulgent Genetics
FLGT
|
1.44 M | $ 15.03 | 1.55 % | $ 454 M | USA |
 |
Chembio Diagnostics
CEMI
|
915 K | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M |  Israel |
 |
Senseonics Holdings
SENS
|
496 K | $ 6.32 | -1.63 % | $ 264 M | USA |
 |
Castle Biosciences
CSTL
|
1.66 M | $ 24.39 | 0.62 % | $ 677 M | USA |
 |
Thermo Fisher Scientific
TMO
|
275 M | $ 472.59 | 1.36 % | $ 178 B | USA |
 |
Illumina
ILMN
|
79 M | $ 125.08 | 3.91 % | $ 19.9 B | USA |
 |
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | USA |
 |
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M |  China |
 |
Twist Bioscience Corporation
TWST
|
13.8 M | $ 58.35 | 2.9 % | $ 3.49 B | USA |
 |
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
57.7 M | $ 163.78 | -0.04 % | $ 8.12 B | USA |
 |
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | USA |
 |
Guardant Health
GH
|
27.7 M | $ 84.43 | 1.22 % | $ 10.6 B | USA |
 |
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
431 K | $ 1.99 | 2.9 % | $ 8.8 M | USA |
 |
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
358 K | $ 2.16 | - | $ 4.96 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
191 M | $ 262.98 | 2.27 % | $ 21.9 B | USA |
 |
Celcuity
CELC
|
54 K | $ 119.89 | 0.74 % | $ 5.61 B | USA |
 |
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
5.64 M | $ 9.23 | 2.39 % | $ 2 B | USA |
 |
Invitae Corporation
NVTA
|
14.6 M | - | - | $ 21.2 M | USA |
 |
Myriad Genetics
MYGN
|
6.9 M | $ 4.71 | 0.64 % | $ 436 M | USA |
 |
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | USA |
 |
Natera
NTRA
|
7.64 M | $ 199.41 | 2.39 % | $ 19.6 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
174 M | $ 193.35 | 2.13 % | $ 21.5 B | USA |